Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including… read more.
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with… read more.
A study of data from over 9.000 pregnancies in the U.S. indicates that cannabis exposure during pregnancy is associated with a composite of unhealthy pregnancy outcomes, especially low… read more.
Researchers from a new meta-analysis of data report that, in addition to its known benefits, sodium glucose co-transporter-2 inhibitor (SGLT2) treatment reduces the risk of adverse kidney and… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
